Cynata Therapeutics Limited (ASX:CYP) Requests Trading Halt
Cynata Therapeutics Limited (ASX:CYP) has announced a trading halt pending a significant clinical trial update.
Category: Healthcare
Acrux Limited (ASX:ACR) Receives FDA Approval for Nitroglycerin Ointment
Acrux Limited has received FDA approval for Nitroglycerin Ointment, expanding its portfolio in the topical market.
Pro Medicus Limited (ASX:PME) Co-Founders Sell Shares
Pro Medicus co-founders Dr Sam Hupert and Mr Anthony Hall sell shares, reaffirming their commitment and retaining significant holdings.
Black Dragon Gold (ASX:BDG) Faces Setback at Salave Project
Black Dragon Gold faces permitting delays as its land re-zoning application for the Salave Gold Project is rejected by local council.
4DMedical Limited (ASX:4DX) Signs Contract with Perth Radiological Clinic
4DMedical Limited announces a contract with Perth Radiological Clinic to enhance lung diagnostics using XV Technology across multiple clinics.
Athena Resources Limited (ASX:AHN) Announces Entitlement Offer
Athena Resources (ASX:AHN) announces a fully underwritten A$2.67 million entitlement offer to fund its Byro Magnetite Project.
Chorus Limited (ASX:CNU) Announces Strategic Reset and FY25 Guidance
Chorus Limited outlines its strategic reset and financial guidance during its Investor Day 2024.
Atturra Limited (ASX:ATA) Completes Acquisition of Plan B
Atturra Limited (ASX:ATA) has completed the acquisition of Plan B, enhancing its managed services and expanding its reach in New Zealand.
AnteoTech Ltd (ASX: ADO) Expands Partnerships in Indian Healthcare Market
AnteoTech Ltd (ASX: ADO) announces vital commercial engagements in the expanding Indian healthcare market.
Micro-X Ltd (ASX:MX1) Responds to US Government Contract Notification
Micro-X Ltd is in advanced stages regarding a US$8.15 million development contract yet to receive full execution.